A Study of HBM9161 in NMOSD Patients

Clinical trial NCT04227470 · COMPLETED

Trial details

NCT number: NCT04227470
Sponsor: Harbour BioMed (Guangzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NMO Spectrum Disorder

Start date: 2020-03-31
Primary completion: 2021-12-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.